Marshall Wace North America’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-147,025
| Closed | -$396K | – | 1688 |
|
|
2020
Q3 | $396K | Sell |
147,025
-118,782
| -45% | -$320K | ﹤0.01% | 1016 |
|
|
2020
Q2 | $731K | Sell |
265,807
-42,213
| -14% | -$116K | ﹤0.01% | 849 |
|
|
2020
Q1 | $728K | Buy |
308,020
+256,533
| +498% | +$606K | 0.01% | 682 |
|
|
2019
Q4 | $242K | Buy |
51,487
+33,312
| +183% | +$157K | ﹤0.01% | 934 |
|
|
2019
Q3 | $61K | Sell |
18,175
-23,839
| -57% | -$80K | ﹤0.01% | 1135 |
|
|
2019
Q2 | $138K | Sell |
42,014
-21
| -0% | -$69 | ﹤0.01% | 1061 |
|
|
2019
Q1 | $128K | Buy |
42,035
+21
| +0% | +$64 | ﹤0.01% | 1072 |
|
|
2018
Q4 | $115K | Buy |
+42,014
| New | +$115K | ﹤0.01% | 1056 |
|
|
2017
Q3 | – | Sell |
-128,920
| Closed | -$387K | – | 1588 |
|
|
2017
Q2 | $387K | Buy |
+128,920
| New | +$387K | ﹤0.01% | 1131 |
|